292 related articles for article (PubMed ID: 29091447)
1. Probing Pharmaceutical Mixtures during Milling: The Potency of Low-Frequency Raman Spectroscopy in Identifying Disorder.
Walker G; Römann P; Poller B; Löbmann K; Grohganz H; Rooney JS; Huff GS; Smith GPS; Rades T; Gordon KC; Strachan CJ; Fraser-Miller SJ
Mol Pharm; 2017 Dec; 14(12):4675-4684. PubMed ID: 29091447
[TBL] [Abstract][Full Text] [Related]
2. Disproportionation of a crystalline citrate salt of a developmental pharmaceutical compound: characterization of the kinetics using pH monitoring and online Raman spectroscopy plus quantitation of the crystalline free base form in binary physical mixtures using FT-Raman, XRPD and DSC.
Skrdla PJ; Zhang D
J Pharm Biomed Anal; 2014 Mar; 90():186-91. PubMed ID: 24378612
[TBL] [Abstract][Full Text] [Related]
3. Physical characterization and stability of amorphous indomethacin and ranitidine hydrochloride binary systems prepared by mechanical activation.
Chieng N; Aaltonen J; Saville D; Rades T
Eur J Pharm Biopharm; 2009 Jan; 71(1):47-54. PubMed ID: 18644443
[TBL] [Abstract][Full Text] [Related]
4. Quantification of gabapentin polymorphs in gabapentin/excipient mixtures using solid state
Tinmanee R; Larsen SC; Morris KR; Kirsch LE
J Pharm Biomed Anal; 2017 Nov; 146():29-36. PubMed ID: 28843174
[TBL] [Abstract][Full Text] [Related]
5. Screening for differences in the amorphous state of indomethacin using multivariate visualization.
Savolainen M; Heinz A; Strachan C; Gordon KC; Yliruusi J; Rades T; Sandler N
Eur J Pharm Sci; 2007 Feb; 30(2):113-23. PubMed ID: 17169536
[TBL] [Abstract][Full Text] [Related]
6. [The development of co-amorphous drug systems].
Yao J; Shi NQ; Wang XL
Yao Xue Xue Bao; 2013 May; 48(5):648-54. PubMed ID: 23888685
[TBL] [Abstract][Full Text] [Related]
7. Investigation of properties and recrystallisation behaviour of amorphous indomethacin samples prepared by different methods.
Karmwar P; Graeser K; Gordon KC; Strachan CJ; Rades T
Int J Pharm; 2011 Sep; 417(1-2):94-100. PubMed ID: 21182910
[TBL] [Abstract][Full Text] [Related]
8. X-ray powder diffractometry in combination with principal component analysis--a tool for monitoring solid state changes.
Kogermann K; Veski P; Rantanen J; Naelapää K
Eur J Pharm Sci; 2011 Jul; 43(4):278-89. PubMed ID: 21575718
[TBL] [Abstract][Full Text] [Related]
9. Mapping the solid-state properties of crystalline lysozyme during pharmaceutical unit-operations.
Mohammad MA; Grimsey IM; Forbes RT
J Pharm Biomed Anal; 2015 Oct; 114():176-83. PubMed ID: 26068908
[TBL] [Abstract][Full Text] [Related]
10. Investigation of physical properties and stability of indomethacin-cimetidine and naproxen-cimetidine co-amorphous systems prepared by quench cooling, coprecipitation and ball milling.
Lim AW; Löbmann K; Grohganz H; Rades T; Chieng N
J Pharm Pharmacol; 2016 Jan; 68(1):36-45. PubMed ID: 26663364
[TBL] [Abstract][Full Text] [Related]
11. Application of Low- and Mid-Frequency Raman Spectroscopy to Characterize the Amorphous-Crystalline Transformation of Indomethacin.
Larkin PJ; Wasylyk J; Raglione M
Appl Spectrosc; 2015 Nov; 69(11):1217-28. PubMed ID: 26647045
[TBL] [Abstract][Full Text] [Related]
12. Formation Mechanism of Coamorphous Drug-Amino Acid Mixtures.
Jensen KT; Larsen FH; Cornett C; Löbmann K; Grohganz H; Rades T
Mol Pharm; 2015 Jul; 12(7):2484-92. PubMed ID: 26057950
[TBL] [Abstract][Full Text] [Related]
13. Unravelling the relationship between degree of disorder and the dissolution behavior of milled glibenclamide.
Mah PT; Laaksonen T; Rades T; Aaltonen J; Peltonen L; Strachan CJ
Mol Pharm; 2014 Jan; 11(1):234-42. PubMed ID: 24224572
[TBL] [Abstract][Full Text] [Related]
14. Effect of different preparation methods on the dissolution behaviour of amorphous indomethacin.
Karmwar P; Graeser K; Gordon KC; Strachan CJ; Rades T
Eur J Pharm Biopharm; 2012 Feb; 80(2):459-64. PubMed ID: 22019529
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the microcrystallinity of a drug substance, indomethacin, in a pharmaceutical model tablet by chemometric FT-Raman spectroscopy.
Okumura T; Otsuka M
Pharm Res; 2005 Aug; 22(8):1350-7. PubMed ID: 16078145
[TBL] [Abstract][Full Text] [Related]
16. Quantitative solid-state analysis of three solid forms of ranitidine hydrochloride in ternary mixtures using Raman spectroscopy and X-ray powder diffraction.
Chieng N; Rehder S; Saville D; Rades T; Aaltonen J
J Pharm Biomed Anal; 2009 Jan; 49(1):18-25. PubMed ID: 19081220
[TBL] [Abstract][Full Text] [Related]
17. Assessment of crystalline disorder in cryo-milled samples of indomethacin using atomic pair-wise distribution functions.
Bøtker JP; Karmwar P; Strachan CJ; Cornett C; Tian F; Zujovic Z; Rantanen J; Rades T
Int J Pharm; 2011 Sep; 417(1-2):112-9. PubMed ID: 21182911
[TBL] [Abstract][Full Text] [Related]
18. Amorphization of Indomethacin by Co-Grinding with Neusilin US2: amorphization kinetics, physical stability and mechanism.
Bahl D; Bogner RH
Pharm Res; 2006 Oct; 23(10):2317-25. PubMed ID: 16927179
[TBL] [Abstract][Full Text] [Related]
19. Using the low-frequency Raman spectroscopy to analyze the crystallization of amorphous indomethacin.
Hédoux A; Paccou L; Guinet Y; Willart JF; Descamps M
Eur J Pharm Sci; 2009 Sep; 38(2):156-64. PubMed ID: 19591926
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of analytical tools and multivariate methods for quantification of co-former crystals in ibuprofen-nicotinamide co-crystals.
Soares FL; Carneiro RL
J Pharm Biomed Anal; 2014 Feb; 89():166-75. PubMed ID: 24291798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
